English  |  正體中文  |  简体中文  |  Items with full text/Total items : 90453/105671 (86%)
Visitors : 15700681      Online Users : 163
RC Version 6.0 © Powered By DSPACE, MIT. Enhanced by NTU Library IR team.
Scope Tips:
  • please add "double quotation mark" for query phrases to get precise results
  • please goto advance search for comprehansive author search
  • Adv. Search
    HomeLoginUploadHelpAboutAdminister Goto mobile version

    Please use this identifier to cite or link to this item: http://asiair.asia.edu.tw/ir/handle/310904400/16682

    Title: Drug design for hemagglutinin: Screening and molecular dynamics from traditional Chinese medicine database
    Authors: 蔡輔仁;Tsai, Fuu-Jen;陳語謙;Chen, Calvin Yu-Chian
    Contributors: 生物科技學系
    Keywords: H1N1;Influenza virus;Docking;Molecular dynamics;Traditional Chinese medicine (TCM) database
    Date: 2011-07
    Issue Date: 2012-11-23 17:15:51 (UTC+8)
    Abstract: Since the outbreak of Swine flu, H1N1 virus had caused a global pandemic and resulted in more than 18,000 deaths over the world as dated on August 2010. Influenza virus surface glycoprotein, hemagglutinin, holds a critical role in mediating viral entry into host cell. Currently, there is no available hemagglutinin binding inhibitor, and already, influenza virus strains resistant to front-line antivirals have been discovered. Here, we report two rosmaricine derivatives might be potent leads which screening from the world largest traditional Chinese medicine database. The docking results shown the rosmaricine derivatives bind influenza hemagglutinin with high affinity based on binding energy. Both rosmaricine_5 and rosmaricine_16 have high binding energy and have hydrogen bonding with hemagglutinin sialic acid binding site residues, Glu83, Asp103 and Asn104. These interactions persist throughout the molecular dynamics simulation and keep the rosmaricine derivatives in the hemagglutinin sialic acid binding site. From the molecular dynamics results show that a potential hemagglutinin inhibitor should have a protonated amine for interacting with Asp103 and hydroxyl groups for interacting with Glu83 and Asn104. Overall, we suggest our two de novo compounds can become novel antivirals for treating influenza infection.
    Appears in Collections:[生物科技學系] 期刊論文

    Files in This Item:

    File Description SizeFormat

    All items in ASIAIR are protected by copyright, with all rights reserved.

    DSpace Software Copyright © 2002-2004  MIT &  Hewlett-Packard  /   Enhanced by   NTU Library IR team Copyright ©   - Feedback